In an on-going push to regulate the use of antipsychotic medications in nursing facilities, another piece of legislation has failed to pass Congress. The Senate did not pass a proposed regulation that would have standardized protocols for obtaining informed consent before administering antipsychotics for off-label use.
This will not affect the Centers for Medicare & Medicaid Services (CMS) antipsychotic initiative aimed at long-term reductions in the use of antipsychotics in nursing facilities.
Additionally, this will not affect the updates to the Nursing Home Compare website’s display of a facility’s use of antipsychotic medications.
Should you have any questions, please contact:
Todd Selby at 317.977.1440 or email@example.com;
Brian Jent at 317.977.1402 or firstname.lastname@example.org; or
David Bufford at 502.568.9368 or email@example.com,
or your regular Hall Render attorney.